课题基金 / 基金详情

ORAL VS IV TREATMENT OF PYELONEPHRITIS IN CHILDREN 1 TO 12 MONTHS

ORAL VS IV TREATMENT OF PYELONEPHRITIS IN CHILDREN 1 TO 12 MONTHS
1 至 12 个月儿童肾盂肾炎的口服治疗与静脉注射治疗
批准号：
6115528
负责人：
ALEJANDRO HOBERMAN
金额：
$2.06万
依托单位：
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6115528
关键词：
antibiotics clinical research clinical trial phase I human subject human therapy evaluation hyperthermia infant human (0-1 year) intravenous administration kidney disorder chemotherapy kidney imaging /visualization oral administration pediatric pharmacology preschool child (1-5) pyelonephritis radionuclide imaging /scanning urinary tract infection

项目摘要

项目成果

ALEJANDRO HOBERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
1-24个月发热儿童口服与静脉抗菌药物治疗尿路感染的随机临床试验结果的主要衡量指标是由UTI指数引起的肾脏瘢痕形成，这是通过研究进入后6个月获得的DMSA肾脏扫描来确定的。
英文摘要
A randomized clinical trial of oral vs. intravenous antimicrobial treatment for urinary tract infection in febrile children aged 1-24 months. The primary measure of outcome is renal scarring attributable to the index UTI, as determined by DMSA renal scans obtained six months after study entry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media
Efficacy of Antimicrobials in Young Children with AOM
Efficacy of Antimicrobials in Young Children with AOM
海外基金